194 related articles for article (PubMed ID: 29341466)
1. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W
ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466
[TBL] [Abstract][Full Text] [Related]
2. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
3. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
[TBL] [Abstract][Full Text] [Related]
4. Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Harjai KJ; Mehra MR; Ventura HO; Lapeyre YM; Murgo JP; Stapleton DD; Smart FW
Chest; 1997 Nov; 112(5):1298-303. PubMed ID: 9367472
[TBL] [Abstract][Full Text] [Related]
5. Chronic inotropic therapy in end-stage heart failure.
Hauptman PJ; Mikolajczak P; George A; Mohr CJ; Hoover R; Swindle J; Schnitzler MA
Am Heart J; 2006 Dec; 152(6):1096.e1-8. PubMed ID: 17161059
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
[TBL] [Abstract][Full Text] [Related]
7. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
8. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J
J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113
[TBL] [Abstract][Full Text] [Related]
10. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
11. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
Collins JA; Skidmore MA; Melvin DB; Engel PJ
J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
[TBL] [Abstract][Full Text] [Related]
12. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
13. Outpatient parenteral inotropic therapy for advanced heart failure.
Young JB; Moen EK
J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
[TBL] [Abstract][Full Text] [Related]
14. Home Inotropes and Other Palliative Care.
Ginwalla M
Heart Fail Clin; 2016 Jul; 12(3):437-48. PubMed ID: 27371519
[TBL] [Abstract][Full Text] [Related]
15. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure.
Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI
Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942
[TBL] [Abstract][Full Text] [Related]
16. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
[TBL] [Abstract][Full Text] [Related]
17. Hospital in the home.
Montalto M
Aust Fam Physician; 2011 Apr; 40(4):183, 185. PubMed ID: 21744523
[No Abstract] [Full Text] [Related]
18. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
[TBL] [Abstract][Full Text] [Related]
19. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA
Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859
[TBL] [Abstract][Full Text] [Related]
20. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
